Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial
口服索马鲁肽对高危 2 型糖尿病患者心血管危险因素的影响：SOUL 随机临床试验的事后二次分析
期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2026.0245
Mulvagh, Sharon L; Inzucchi, Silvio E; Marx, Nikolaus; Poulter, Neil R; Deanfield, John E; Pop-Busui, Rodica; Emerson, Scott S; Mann, Johannes F E; Engelmann, Mads D M; Hovingh, G Kees; Mandavya, Kabirdev; Davicevic-Elez, Zaklina; Jeppesen, Ole Kleist; Lorenzatti, Alberto; Oguz, Aytekin; Mankovsky, Boris; Deerochanawong, Chaicharn; Gorgojo-Martinez, Juan J; Ji, Linong; Bain, Stephen C; McGuire, Darren K; Buse, John B
